Israel’s Oncohost is working with Israel’s Technion to develop cutting-edge technology to characterize, analyze and predict patient response and resistance to cancer therapy. This enables personalized treatment strategies with improved outcomes & reduced side effects.
https://www.jpost.com/Jpost-Tech/Hillels-Tech-Corner-Cancer-treatment-personalized-610032